SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-09-004628
Filing Date
2009-01-23
Accepted
2009-01-23 17:22:19
Documents
1
Period of Report
2009-01-22

Document Format Files

Seq Description Document Type Size
1 OPEN MARKET PURCHASE rrd230816.html 4  
1 OPEN MARKET PURCHASE rrd230816.xml 4 10007
  Complete submission text file 0001181431-09-004628.txt   11927
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2170 BUCKTHORNE PLACE SUITE 170 THE WOODLAND TX 77380
Business Address 2170 BUCKTHORNE PLACE SUITE 170 THE WOODLANDS TX 77380 7133679999
SUTTER MARTIN P (Reporting) CIK: 0001017832 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-24274 | Film No.: 09543216